F-1/A: Park Ha Biological Technology Co., Ltd. Files Amendment No. 5 for Initial Public Offering

Park Ha Biological Technology Co., Ltd. has filed an amendment to its registration statement for an initial public offering of 1,200,000 ordinary shares, with an expected price range of $4.00 to $6.00 per share.

Summary

• Park Ha Biological Technology Co., Ltd., a Cayman Islands holding company, is planning an initial public offering of 1,200,000 ordinary shares.
• The company expects the initial public offering price to be between $4.00 and $6.00 per share.
• The offering is contingent upon listing the ordinary shares on Nasdaq or another national exchange.
• Park Ha Cayman controls its operating subsidiaries in China through equity ownership.
• The company's revenue is primarily derived from product sales and franchise fees.
• For the six months ended April 30, 2024, total revenue was $852,928, a decrease of 37.81% compared to the same period in 2023.
• The decrease in revenue was primarily due to a decrease in franchise fees, which fell by $594,398.
• The company's net income decreased by 90.22% to $48,900 for the six months ended April 30, 2024.
• The company is an emerging growth company and will be subject to reduced public company reporting requirements.
• The CEO, Xiaoqiu Zhang, will beneficially own approximately 72.7% of the voting power after the offering, making it a controlled company.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant financial challenges, including a substantial decrease in revenue and net income, alongside some positive aspects like a diversified management team and a franchise model. The risks associated with operating in China and the potential for regulatory hurdles add to the negative sentiment.

Positives

• The company has a research and development center focused on skincare product development.
• The company has a franchise model with stores in various provinces in China.
• The company is actively broadening its online sales channels to attract more customers.
• The company has a strong and diversified management team with experience in beauty, fashion, retail, and internet industries.
• The company has a stable supply chain system with suppliers located in various provinces in China.

Negatives

• The company experienced a significant decrease in revenue and net income for the six months ended April 30, 2024.
• The company relies on third-party manufacturers for product formulas.
• The company faces intense competition in the skincare industry.
• The company has a limited operating history.
• The company is subject to legal and operational risks associated with having all business operations in China.
• The company may be prohibited from trading on a national exchange under the Holding Foreign Companies Accountable Act (the HFCAA) if the Public Company Accounting Oversight Board (the PCAOB) is unable to inspect the company's auditors for two consecutive years.
• The company is required to complete the record filing requirement with the CSRC to list on overseas stock exchanges and may not be able to complete the filing because the filing materials are incomplete or do not meet the requirements of the CSRC.

Risks

• The company's ability to pay dividends is primarily dependent on the earnings of its operating subsidiaries.
• The company's results of operation may be materially and adversely affected by a change in China or the global economy.
• The company may face challenges in maintaining product consistency and quality.
• The company may face liability resulting from acts of its franchisees.
• The company may be subject to civil complaints and regulatory actions under certain PRC laws and regulations relating to labor, social insurance and housing provident funds.
• The company may be exposed to liabilities under the Foreign Corrupt Practices Act and Chinese anti-corruption law.
• The company may not be able to use certain of its leased properties due to failure to comply with PRC laws and regulations on leased property.
• The company may be subject to the risk of non-payments or delayed payments by its customers.
• The company may be subject to the risk of non-payments or delayed payments by its customers.
• The company may be subject to the risk of non-payments or delayed payments by its customers.

Future Outlook

The company intends to retain most, if not all, of its available funds and any future earnings after this offering to the development and growth of the business in China and does not expect to pay dividends in the foreseeable future.

Management Comments

• Our management monitors the cash position of each entity within our organization regularly and prepare monthly budgets to ensure each entity has the necessary funds to fulfill its obligation for the foreseeable future and to ensure adequate liquidity.
• In the event that there is any current or potential liquidity issue, it will be reported to our Chief Financial Officer and subject to approval by our board of directors, we will enter into an intercompany loan for the applicable subsidiary.

Industry Context

The company operates in the competitive skincare and cosmetics industry in China, facing competition from both domestic and international players. The company is using a franchise model to expand its reach.

Comparison to Industry Standards

• The company's revenue decrease of 37.81% for the six months ended April 30, 2024, is a significant deviation from the growth trends seen in many other companies in the beauty and personal care sector.
• The company's reliance on franchise fees for a large portion of its revenue is a different model than many other companies in the beauty and personal care sector, which tend to rely more on direct sales.
• The company's net income decrease of 90.22% for the six months ended April 30, 2024, is a significant deviation from the performance of many other companies in the beauty and personal care sector.
• The company's reliance on a limited number of suppliers is a risk that is not as prevalent in larger, more established companies in the beauty and personal care sector.
• The company's cash subsidies to franchisees are a unique approach that is not commonly seen in other companies in the beauty and personal care sector.

Related Party Transactions

• The Company made advances to Mr. Hengquan Zhang for working capital to be paid on behalf of the Company.
• The Company made advances to Mr. Fujun Yu for working capital to be paid on behalf of the Company.
• The Company received advances from Mr. Fujun Yu as working capital.
• The Company received advances from Ms. Guozhen Liu as working capital.
• The Company received advances from Ms. Xiaoqiu Zhang as working capital.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Shareholders may face difficulties in enforcing judgments against the company and its officers and directors.
• Employees may be affected by changes in the company's operations and financial performance.
• Customers may be affected by changes in the company's product offerings and service quality.
• Suppliers may be affected by changes in the company's purchasing patterns and financial stability.
• Creditors may be affected by changes in the company's financial performance and ability to repay debts.

Next Steps

• The company intends to use the proceeds from this offering for expanding the scale of its directly-owned stores, purchasing existing product patents, and acquiring its ingredients suppliers.
• The company plans to expand its partnership with scientific research institutions to develop new skincare raw materials and products.
• The company plans to open vocational training schools to provide professional training to its franchisee staff.
• The company will continue to seek to improve brand awareness by using social media platforms.
• The company plans to establish partnerships with third-party warehouse and distribution centers to support its businesses.
• The company will evaluate and selectively seek strategic alliances, investment and acquisition opportunities in the beauty industry across China.

Key Dates

Keywords

Initial Public Offering, Skincare, Cosmetics, Franchise, China, Nasdaq, Holding Company, Beauty Products, Operating Subsidiaries, Financial Results